CIK 0001764013 · Large accelerated filer
Immunovant, Inc.
Sign in to watch- Ticker
- IMVT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832771572
- Phone
- 917-410-3120
- Business address
- 1000 PARK FORTY PLAZA, DURHAM, NC, 27713
- Former names
- Health Sciences Acquisitions Corp
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SC 13G/A Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- DEF 14A Proxy Proxy Statement
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- SC 13G Stake Amended Statement of Ownership
Page 1 of 2 · 40 filings